Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

CTP-543 is generally safe for treating alopecia areata.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

An 11-year-old girl with severe hair loss regrew and repigmented her hair after JAK inhibitor treatment.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Ritlecitinib is safe for treating alopecia areata for up to 48 weeks.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib is effective for treating alopecia areata, showing significant hair regrowth with mild side effects.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Deuruxolitinib and baricitinib are effective for treating severe alopecia areata.

The rash resolved after stopping ponatinib.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.